Xu W - Search Results

1

Energy sources identify metabolic phenotypes in pancreatic cancer.

Liang C, Qin Y, Zhang B, Ji S, Shi S, Xu W, Liu J, Xiang J, Liang D, Hu Q, Liu L, Liu C, Luo G, Ni Q, Xu J, Yu X. Liang C, et al. Among authors: xu w, xu j. Acta Biochim Biophys Sin (Shanghai). 2016 Nov;48(11):969-979. doi: 10.1093/abbs/gmw097. Epub 2016 Sep 20. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 27649892 Free article. Review.

2

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.

Ji S, Xu J, Zhang B, Yao W, Xu W, Wu W, Xu Y, Wang H, Ni Q, Hou H, Yu X. Ji S, et al. Among authors: xu w, xu y, xu j. Cancer Biol Ther. 2012 Feb 15;13(4):206-15. doi: 10.4161/cbt.13.4.18692. Cancer Biol Ther. 2012. PMID: 22354009

3

Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.

Xu J, Zhu W, Xu W, Cui X, Chen L, Ji S, Qin Y, Yao W, Liu L, Liu C, Long J, Li M, Yu X. Xu J, et al. Among authors: xu w. Int J Oncol. 2013 Jun;42(6):2046-52. doi: 10.3892/ijo.2013.1901. Epub 2013 Apr 16. Int J Oncol. 2013. PMID: 23588667

4

TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.

Li J, Chen L, Zhang Y, Zhang WJ, Xu W, Qin Y, Xu J, Zou D. Li J, et al. Among authors: xu w, xu j. Acta Biochim Biophys Sin (Shanghai). 2013 Dec;45(12):1030-8. doi: 10.1093/abbs/gmt092. Epub 2013 Aug 28. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23985305 Free article.

5

Ligamentum teres hepatis patch enhances the healing of pancreatic fistula after distal pancreatectomy.

Wu CT, Xu WY, Liu L, Long J, Xu J, Ni QX, Liu C, Yu XJ. Wu CT, et al. Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):651-5. doi: 10.1016/s1499-3872(13)60102-2. Hepatobiliary Pancreat Dis Int. 2013. PMID: 24322752

6

LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process.

Qin Y, Zhu W, Xu W, Zhang B, Shi S, Ji S, Liu J, Long J, Liu C, Liu L, Xu J, Yu X. Qin Y, et al. Among authors: xu w, xu j. Cancer Lett. 2014 Jun 1;347(2):225-32. doi: 10.1016/j.canlet.2014.02.013. Epub 2014 Feb 18. Cancer Lett. 2014. PMID: 24561118

7

Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis.

Yao W, Ji S, Qin Y, Yang J, Xu J, Zhang B, Xu W, Liu J, Shi S, Liu L, Liu C, Long J, Ni Q, Li M, Yu X. Yao W, et al. Among authors: xu w, xu j. Mol Cancer. 2014 Aug 7;13:187. doi: 10.1186/1476-4598-13-187. Mol Cancer. 2014. PMID: 25103363 Free PMC article.

8

Metabolic tumor burden is associated with major oncogenomic alterations and serum tumor markers in patients with resected pancreatic cancer.

Shi S, Ji S, Qin Y, Xu J, Zhang B, Xu W, Liu J, Long J, Liu C, Liu L, Ni Q, Yu X. Shi S, et al. Among authors: xu w, xu j. Cancer Lett. 2015 May 1;360(2):227-33. doi: 10.1016/j.canlet.2015.02.014. Epub 2015 Feb 14. Cancer Lett. 2015. PMID: 25687883

9

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.

Ji S, Qin Y, Shi S, Liu X, Hu H, Zhou H, Gao J, Zhang B, Xu W, Liu J, Liang D, Liu L, Liu C, Long J, Zhou H, Chiao PJ, Xu J, Ni Q, Gao D, Yu X. Ji S, et al. Among authors: xu w, xu j. Cell Res. 2015 May;25(5):561-73. doi: 10.1038/cr.2015.30. Epub 2015 Mar 10. Cell Res. 2015. PMID: 25753158 Free PMC article.

10

Papillary-like main pancreatic duct invaginated pancreaticojejunostomy versus duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: A prospective randomized trial.

Xu J, Zhang B, Shi S, Qin Y, Ji S, Xu W, Liu J, Liu L, Liu C, Long J, Ni Q, Yu X. Xu J, et al. Among authors: xu w. Surgery. 2015 Nov;158(5):1211-8. doi: 10.1016/j.surg.2015.04.020. Epub 2015 May 30. Surgery. 2015. PMID: 26036878 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27,997 results

Search Page